NSCLC | Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non-Small Cell Lung Cancer
Free with Audible trial. Cancel anytime.
Quick Facts
| Author | Unknown |
| Narrator | Unknown |
| Runtime | 0h50m |
| Published | December 2, 2019 |
| Rating | 4.5 / 5 (1 ratings) |
| Categories | Health & Wellness, Physical Illness & Disease, Hygiene & Healthy Living, Science & Engineering, Science |
| Format | Audiobook (Digital) |
| Platform | Audible |
Featured Audiobooks
Handpicked listeners' favorites this week
About This Audiobook
Faculty presentations from a CME symposium held during the ASTRO 2019 Annual Meeting. Featuring perspectives from moderator Dr Corey J Langer and ...
Why Listen to NSCLC | Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non-Small Cell Lung Cancer?
- Expert narration by Unknown brings every character and scene to life across 0h50m of immersive audio.
- Bestseller-quality story from Unknown, rated 4.5 stars by 1 listeners.
- Free with your Audible trial — keep the audiobook forever even if you cancel.
- Perfect for commutes, workouts, and relaxation. Listen anywhere, anytime.
Download: NSCLC | Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non-Small Cell Lung Cancer
Some links on this page are affiliate links. If you make a purchase through one of them, we may earn a small commission at no extra cost to you.
NSCLC | Consensus or Controversy? Radiation and Medical Oncology Investigator Perspectives on the Role of Immune Checkpoint Inhibition in the Management of Locally Advanced Non-Small Cell Lung Cancer by Unknown is an immersive listening experience. Performed by Unknown with a runtime of 0h50m, you can start with a free trial that you can cancel at any time. The audiobook remains yours forever, even if you end the trial.